|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
CRISPR Therapeutics
| | | Phone: | (617) 580-9212 | Year Established: | 2013 | Ticker: | CRSP | Exchange: | NASDAQ | Main Contact: | Samarth Kulkarni, Ph.D., President & CEO | | Other Contacts: | Rodger Novak, Chairman Michael Tomsicek, CFO Tony W. Ho, M.D., Executive VP & Head, R& D Jon Terrett, Ph.D., Head of Immuno-Oncology Research & Translation Shelby Walker, Head of Intellectual Property Michael Bruce, Ph.D., Senior VP, Program Portfolio & Alliance Management Bill Lundberg, MD, MBA, CSO
| | Company Description | The mission of CRISPR Therapeutics is to develop transformative gene-based medicines for patients with serious diseases. Their therapeutic approach aims to cure diseases at the molecular level using the breakthrough gene editing technology called CRISPR-Cas9. They have licensed the foundational CRISPR-Cas9 patent estate for human therapeutic use from our scientific founder, Dr. Emmanuelle Charpentier. | |
|
|
|
|
|